Prescription Intelligence Prescription Decision Support News
Menu

RxREVU

The Leader in Prescription Decision Support

×

Author: rxrevu

  • UCHealth and RxREVU Partner to Fight Antibiotic Resistance

    September 25, 2016

    AURORA, Colo., Sept. 23, 2016 /PRNewswire-iReach/ — AURORA, Colo. (September 22, 2016) – UCHealth, a nationally recognized health care system based in Colorado, is partnering with RxREVU, the leader in … Continue reading UCHealth and RxREVU Partner to Fight Antibiotic Resistance

  • Banner Health Selects RxREVU for Prescription Decision Support

    May 16, 2016

    Denver, CO – Banner Health, a leading health system in the country for clinical quality, has selected RxREVU to provide enhanced prescription decision support. Nonprofit Banner Health is headquartered in … Continue reading Banner Health Selects RxREVU for Prescription Decision Support

  • Anthem Sues Express Scripts for $3 Billion

    March 29, 2016

    There could be a big shake up in the Pharmacy Benefits Manager market this year. Anthem Inc., one of the largest insurance providers, is suing Express Scripts, their PBM, for … Continue reading Anthem Sues Express Scripts for $3 Billion

  • Medication Errors and Adverse Events Found In Many Surgeries at MassGeneral

    March 21, 2016

    “Whoops!” is definitely the last thing you would want to hear from a medical professional after having surgery. Mass General is Harvard’s oldest and largest teaching and research hospital. It … Continue reading Medication Errors and Adverse Events Found In Many Surgeries at MassGeneral

  • Value Based Plan Design Study: Lower Copays Lower Costs Improve Adherence

    March 14, 2016

    Value based insurance design is care that is designed to improve outcomes using financial incentives. It promotes preventative care and efforts to avoid waste, seeking better outcomes through equal, but … Continue reading Value Based Plan Design Study: Lower Copays Lower Costs Improve Adherence

  • Medicare May Not Be Able to Lower Costs Even if it Could Negotiate Prices

    March 7, 2016

    A popular piñata in Mexico this year is Donald Trump’s head. In the US one of the other big political targets is Medicare and its inability to negotiate prices with … Continue reading Medicare May Not Be Able to Lower Costs Even if it Could Negotiate Prices

  • Diabetes Patients Suffer From Skyrocketing Prices of Insulin

    March 3, 2016

    Insulin has been used to treat diabetes since the 1920s. The World Health Organization has placed insulin on its list of essential medications that states it should be “available at … Continue reading Diabetes Patients Suffer From Skyrocketing Prices of Insulin

  • Drug Lobby Spends 38 Million Fighting California Drug Price Relief Act

    February 18, 2016

    Rising prescription drug prices are going to have a big presence on the Presidential campaign trail. With prices rising quickly the last few years, it has become a frequent subject … Continue reading Drug Lobby Spends 38 Million Fighting California Drug Price Relief Act

  • This Article Contains Explicit Language Because It’s About Martin Shkreli

    February 8, 2016

    Is there no such thing as bad publicity? Martin Shkreli offers an interesting test case for this theory. He has been described in the media as, “troubled,” “awful,” “putrid,” “reviled,” “infamous,” “smirky,” as well as … Continue reading This Article Contains Explicit Language Because It’s About Martin Shkreli

  • Sovaldi Pricing May Constitute Unfair Trade Practice Says Mass Attorney General

    February 4, 2016

    Last month Massachusetts Attorney General, Maura Healey, sent a letter to the prescription drug company Gilead. The letter opened a new fight in the state’s efforts to keep prescription drug … Continue reading Sovaldi Pricing May Constitute Unfair Trade Practice Says Mass Attorney General

  • Generic Drug Backlog Just Another Brick in the Wall

    January 29, 2016

    Pete Rose is baseball’s all time career hits leader. He retired with 4,256 hits. He has more than Ty Cobb, Hank Aaron, and Derek Jeter. The FDA has him beat. … Continue reading Generic Drug Backlog Just Another Brick in the Wall

  • 2016 Starts With Double Digit Price Increases

    January 25, 2016

    The double down is a blackjack maneuver where the player is given the chance to double their winnings by agreeing to double their bet and take only one more card … Continue reading 2016 Starts With Double Digit Price Increases

  • Next-Generation Medication Therapy Management Saves Money

    January 21, 2016

    We have recently posted about the difficulty seniors face maintaining their prescription drug adherence. Failure can lead to enormous negative consequences in health outcomes and costs to the system. Hospital … Continue reading Next-Generation Medication Therapy Management Saves Money

  • The Dark Art of Outcome Switching

    January 20, 2016

    Outcome switching is the process of altering the measures of a clinical trial to improve the chances that a drug is approved by the FDA… Specifically, outcome switching is when … Continue reading The Dark Art of Outcome Switching

  • The Case for Machine Learning in Prescribing

    January 18, 2016

    If you ever think your doctor has it easy, consider the following.  A patient comes in and is diagnosed with high blood pressure, high cholesterol, and diabetes.  Unfortunately a common … Continue reading The Case for Machine Learning in Prescribing

  • Big Pharma Uses Coupons to Squeeze Payers

    January 14, 2016

    In the Harry Potter series “muggles,” ordinary people without magical powers, are unaware of a war happening all around them between two groups of wizards. Bloomberg News recently reported on … Continue reading Big Pharma Uses Coupons to Squeeze Payers

Posts navigation

Page 1 Page 2 … Page 4 Next page

Popular Articles

  • Dr. Toby Cosgrove of Cleveland Clinic Joins RxRevu Board
  • Combating Burnout through Physician-Centered Technology
  • RxREVU and Mental Health Center of Denver Partner to Improve Mental Health Prescribing
  • UCHealth and RxREVU Partner to Fight Antibiotic Resistance
  • Banner Health Selects RxREVU for Prescription Decision Support

Categories

  • Case Studies
  • Company News
  • Drug News
  • Healthcare Transparency
  • Industry News
  • Medication Savings
  • Press Releases
  • Value Based Care

Tags

aetna big data cerner change healthcare cost reduction dataset digital health dosage equivalency drug costs drug patents drug prices drug pricing EHR EMR express scripts FHIR generics Gilead government harvard Harvoni healthcare healthcare analytics healthcare transparency HHS high drug costs interoperability medical journals medicare medication optimization medication savings peer reviewed prescription decision support prescription drug costs prescription drugs pubmed regulation rxrevu SMART sovaldi specialty drugs specialty medications startup health transparency value based care

© 2021 RxREVU